Abstract:Deep DCIS evaluates the nuclear grade, necrosis, and stromal reactivity of ADH/DCIS on breast biopsies as continuous variables. DCIS outperforms traditional histological grading in predicting upstaging to invasive carcinoma, and the performance improves after incorporating core clinical features. Aims Risk stratification of atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS), diagnosed using breast biopsy, has great clinical significance. Clinical trials are currently exploring the possibility of active surveillance for low‐risk lesions, whereas axillary lymph node staging may be considered during surgical planning for high‐risk lesions. We aimed to develop a machine‐learning algorithm based on whole‐slide images of breast biopsy specimens and clinical information to predict the risk of upstaging to invasive breast cancer after wide excision. Methods and Results Patients diagnosed with ADH/DCIS on breast biopsy were included in this study, comprising 592 (740 slides) and 141 (198 slides) patients in the development and independent testing cohorts, respectively. Histological grading of the lesions was independently evaluated by two pathologists. Clinical information, including biopsy method, lesion size, and Breast Imaging Reporting and Data System (BI‐RADS) classification of ultrasound and mammograms, were collected. Deep DCIS consisted of three deep neural networks to evaluate nuclear grade, necrosis, and stromal reactivity. Deep DCIS output comprised five parameters: total patches, lesion extent, Deep Grade, Deep Necrosis, and Deep Stroma. Deep DCIS highly correlated with the pathologists' evaluations of both slide‐ and patient‐level labels. All five parameters of Deep DCIS were significantly associated with upstaging to invasive carcinoma in subsequent wide excisional specimens. Using multivariate logistic regression, Deep DCIS predicted upstaging to invasive carcinoma with an area under the curve (AUC) of 0.81, outperforming pathologists' evaluation (AUC, 0.71 and 0.69). After including clinical and hormone receptor status information, performance further improved (AUC, 0.87). This combined model retained its predictive power in two subgroup analyses: the first subgroup included unequivocal DCIS (excluding cases of ADH and DCIS suspicious for microinvasion) (AUC, 0.83), while the second excluded cases of high‐grade DCIS (AUC, 0.81). The model was validated in an independent testing cohort (AUC, 0.81). Conclusion This study demonstrated that deep‐learning models can refine histological evaluation of ADH and DCIS on breast biopsies, which may help guide future treatment planning.

Upstaging Prediction Model to Guide the Application of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ: A Retrospective Comparative Study

Prediction of Sentinel Lymph Node Metastasis in Breast Ductal Carcinoma in Situ Diagnosed by Preoperative Core Needle Biopsy

Predictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta-analysis.

High Risk For Non-Sentinel Node Metastasis In Breast Cancer Patients With Sentinel Node Metastases

Radiological and pathological predictors of post-operative upstaging of breast ductal carcinoma in situ (DCIS) to invasive ductal carcinoma and lymph-nodes metastasis; a potential algorithm for node surgical de-escalation

A Risk Model Based on Ultrasound, Ultrasound Elastography, and Histologic Parameters for Predicting Axillary Lymph Node Metastasis in Breast Invasive Ductal Carcinoma

Is it feasible to selectively perform axillary lymph node surgery for patients with biopsy diagnosed Ductal Carcinoma in Situ? A study based on developed and validation of nomogram

Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy

Validation and Comparison of Models to Predict Non-Sentinel Lymph Node Metastasis in Breast Cancer Patients.

Predicting Axillary Lymph Node Metastasis in Patients with Breast Invasive Ductal Carcinoma with Negative Axillary Ultrasound Results Using Conventional Ultrasound and Contrast‐Enhanced Ultrasound

Factors Associated with Upstaging in Patients Preoperatively Diagnosed with Ductal Carcinoma in Situ by Core Needle Biopsy

Development of a prediction model based on LASSO regression to evaluate the risk of non-sentinel lymph node metastasis in Chinese breast cancer patients with 1–2 positive sentinel lymph nodes

A Prospective Validation Cohort Study of a Prediction Model on Non-Sentinel Lymph Node Involvement in Early Breast Cancer.

Pathologic Nodal Upstaging Predictive Models for CT-based Clinical Node Negative Non-Small Cell Lung Cancer

Analysis of risk factors associated with upstaging in patients with pre-operative diagnosis of ductal carcinoma in situ of breast by core needle biopsy

Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study

A new model to predict risk of nonsentinel lymph node status in Chinese sentinel lymph node-positive patients after neoadjuvant chemotherapy.

A Model Incorporating Axillary Tail Position on Mammography for Preoperative Prediction of Non-sentinel Lymph Node Metastasis in Patients with Initial cN+ Breast Cancer after Neoadjuvant Chemotherapy

Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy—Original Study and Critical Evaluation of the Literature

Axillary Evaluation is Not Warranted in Patients Preoperatively Diagnosed with Ductal Carcinoma in Situ by Core Needle Biopsy

Deep‐learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy